During the past decade, Medcenter One Health System conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medcenter One Health System" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 45 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "Eastern Cooperative Oncology Group" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medcenter One Health System" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Medcenter One Health System" are "Breast Cancer" (18 trials), "Lung Cancer" (9 trials), "Colorectal Cancer" (7 trials), "Prostate Cancer" (6 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "Medcenter One Health System" in a lesser frequency.

Most popular intervention types in "Medcenter One Health System" are "Drug" (54 trials), "Other" (14 trials), "Biological" (9 trials), "Radiation" (9 trials) and "Dietary Supplement" (7 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (13 trials), "gemcitabine hydrochloride" (11 trials), "radiation therapy" (8 trials), "cisplatin" (7 trials) and "fluorouracil" (7 trials). Other intervention names were less common.

The vast majority of trials in "Medcenter One Health System" are 47 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Medcenter One Health System". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Medcenter One Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medcenter One Health System, 2 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Medcenter One Health System has several departments that took part in Clinical trials: "Neuropsychiatric Research Institute" - 17 trials